Monolayer-capped gold nanoparticles for disease detection from breath

Nanomedicine

Volumn 9, Issue 13, 2014, Pages 1991-2002

  Nakhleh, Morad K ^a   Broza, Yoav Y ^a   Haick, Hossam ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

breath; detection; gold nanoparticle; sensor

Indexed keywords

GOLD NANOPARTICLE; MONOLAYER CAPPED GOLD NANOPARTICLE; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND; GOLD; METAL NANOPARTICLE;

ACUTE KIDNEY FAILURE; BREAST CANCER; BREATH ANALYSIS; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; LUNG TUBERCULOSIS; NEUROLOGIC DISEASE; NON INVASIVE PROCEDURE; PATTERN RECOGNITION; POINT OF CARE TESTING; PULMONARY HYPERTENSION; REVIEW; SENSOR; SPECTROMETRY; SPECTROSCOPY; STOMACH CANCER; CHEMISTRY; DIAGNOSIS; DIAGNOSTIC USE; ISOLATION AND PURIFICATION; MASS FRAGMENTOGRAPHY;

BREATH TESTS; DIAGNOSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GOLD; HUMANS; METAL NANOPARTICLES; VOLATILE ORGANIC COMPOUNDS;

EID: 84908288513     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.121     Document Type: Review

References (61)

1. Haick H, Broza YY, Mochalski P, Ruzsanyi V, Amann A. Assessment, origin, and implementation of breath volatile cancer markers. Chem. Soc. Rev. 43, 1423-1449 (2014).
2. Amann A, Mochalski P, Ruzsanyi V, Broza YY, Haick H. Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties. J. Breath Res. 8(1), 016003 (2014).
3. Konvalina G, Haick H. Sensors for breath testing: From nanomaterials to comprehensive disease detection. Acc. Chem. Res. 47, 66-76 (2014).
4. Broza YY, Haick H. Nanomaterial-based sensors for detection of disease by volatile organic compounds. Nanomedicine (Lond.) 8, 785-806 (2013).
5. Amann A, Corradi M, Mazzone P, Mutti A. Lung cancer biomarkers in exhaled breath. Expert Rev. Mol. Diagn. 11, 207-217 (2011).
6. Tisch U, Haick H. Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing. Rev. Chem. Eng. 26, 171-179 (2010).
7. Hakim M, Broza Y, Barash O et al. Volatile organic compounds of lung cancer and possible biochemical pathways. Chem. Rev. 112, 5949-5966 (2012).
8. Peng G, Hakim M, Broza YY et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br. J. Cancer 103, 542-551 (2010).
9. Miekisch W, Schubert JK, Noeldge-Schomburg GFE. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin. Chim. Acta 347, 25-39 (2004).
10. Amann A, Ligor M, Ligor T et al. Analysis of exhaled breath for screening of lung cancer patients. Memo 3, 106-112 (2010).
11. Peng G, Tisch U, Adams O et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat. Nanotechol. 4, 669-673 (2009).
12. Phillips M, Basa-Dalay V, Bothamley G et al. Breath biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb.) 90, 145-151 (2010).
13. Phillips M, Cataneo RN, Cummin ARC et al. Detection of lung cancer with volatile markers in the breath. Chest 123, 2115-2123 (2003).
14. Xu ZQ, Broza YY, Ionsecu R et al. The breathprints of gastric cancer and benign gastric conditions. Br. J. Cancer 108, 941-950 (2012).
15. Paska YS, Stelzner T, Tisch U, Assad O, Christiansen S, Haick H. Molecular gating of silicon nanowire field effect transistors with nonpolar analytes. ACS Nano 6, 335-345 (2012).
16. Konvalina G, Haick H. The effect of humidity on nanoparticle-based chemiresistors: A comparison between synthetic and real-world samples. ACS Appl. Mater. Interf. 4, 317-325 (2012).
17. Paska Y, Haick H. Interactive effect of hysteresis and surface chemistry on gated silicon nanowire gas sensors. ACS Appl. Mater. Interf. 4, 2604-2617 (2012).
18. Assady S, Marom O, Hemli M et al. Impact of hemodialysis on exhaled volatile organic compounds in end-stage renal disease: A pilot study. Nanomedicine (Lond.) 9(7), 1035-1045 (2014).
19. Paska Y, Stelzner T, Christiansen S, Haick H. Enhanced sensing of nonpolar volatile organic compounds by silicon nanowire field effect transistors. ACS Nano 5, 5620-5626 (2011).
20. Chen CY, Kuo YT, Lee CH et al. Differentiation between malignant and benign gastric ulcers: CT virtual gastroscopy versus optical gastroendoscopy. Radiology 252, 410-417 (2009).
21. Zilberman Y, Ionescu R, Feng X, Mullen K, Haick H. Nanoarray of polycyclic aromatic hydrocarbons and carbon nanotubes for accurate and predictive detection in real-world environmental humidity. ACS Nano 5, 6743-6753 (2011).
22. Zilberman Y, Tisch U, Shuster G et al. Carbon nanotube/ hexa-peri-hexabenzocoronene bilayers for discrimination between nonpolar volatile organic compounds of cancer and humid atmospheres. Adv. Mater. 22, 4317-4320 (2010).
23. Ionescu R, Broza Y, Shaltieli H et al. Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes. ACS Chem. Neurosci. 2, 687-693 (2011).
24. Peng G, Tisch U, Haick H. Detection of nonpolar molecules by means of carrier scattering in random networks of carbon nanotubes: Toward diagnosis of diseases via breath samples. Nano Lett. 9, 1362-1368 (2009).
25. Peng G, Trock E, Haick H. Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with non-polymeric organic materials. Nano Lett. 8, 3631-3635 (2008).
26. Wallis RS, Pai M, Menzies D et al. Biomarkers and diagnostics for tuberculosis: Progress, needs, and translation into practice. Lancet 375, 1920-1937 (2010).
27. Daniel MC, Astruc D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104, 293-346 (2004).
28. Haick H. Chemical sensors based on molecularly modified metallic nanoparticles. J. Phys. D 40, 7173-7186 (2007).
29. Dovgolevsky E, Konvalina G, Tisch U, Haick H. Monolayer-capped cubic platinum nanoparticles for sensing nonpolar analytes in highly humid atmospheres. J. Phys. Chem. C 114, 14042-14049 (2010).
30. Dovgolevsky E, Tisch U, Haick H. Chemically sensitive resistors based on monolayer-capped cubic nanoparticles: Towards configurable nanoporous sensors. Small 5, 1158-1161 (2009).
31. Dovgolevsky E, Haick H. Direct observation of the transition point between quasi-spherical and cubic nanoparticles in two-step seed-mediated growth method. Small 4, 2059-2066 (2008).
32. Segev-Bar M, Shuster G, Haick H. The effect of perforation on the sensing properties of monolayer-capped metallic nanoparticle films. J. Phys. Chem. C 116, 15361-15368 (2012).
33. Thaler ER, Hanson CW. Medical applications of electronic nose technology. Expert Rev. Med. Dev. 2, 559-566 (2005).
34. Tisch U, Haick H. Nanomaterials for cross-reactive sensor arrays. MRS Bull. 35, 797-803 (2010).
35. Joseph Y, Guse B, Vossmeyer T, Yasudaa A. Gold nanoparticle/organic networks as chemiresistor coatings: The effect of film morphology on vapor sensitivity. J. Phys. Chem. C 112, 12507-12514 (2008).
36. Goepel W. Chemical sensing, molecular electronics and nanotechnology: Interface technologies down to the molecular scale. Sens. Actuat. B 4, 7-21 (1991).
37. Rock F, Barsan N, Weimar U. Electronic nose: Current status and future trends. Chem. Rev. 108, 705-725 (2008).
38. Hu WT, Chen-Plotkin A, Arnold SE et al. Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol. 120, 385-399 (2010).
39. Schrag A, Ben-Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community?. J. Neurol. Neurosurg. Psychiatry 73, 529-534 (2002).
40. Tisch U, Schlesinger I, Ionescu R et al. Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors. Nanomedicine (Lond.) 8, 43-56 (2012).
41. Marom O, Nakhoul F, Tisch U, Shiban A, Abassi Z, Haick H. Gold nanoparticle sensors for detecting chronic kidney disease and disease progression. Nanomedicine (Lond.) 7, 639-650 (2012).
42. Nakhleh MK, Amal H, Awad A et al. Sensor arrays based on nanoparticles for early detection of kidney injury by breath samples. Nanomedicine doi:10.1016/j.nano.2014.06.007 (2014) (Epub ahead of print).
43. Nakhleh MK, Jeries R, Gharra A et al. Detecting active pulmonary tuberculosis with a breath test using nanomaterial-based sensors. Eur. Respir. J. 43, 1522-1525 (2014).
44. Peled N, Hakim M, BunnPAJr et al. Non-invasive breath analysis of pulmonary nodules. J. Thorac. Oncol. 7, 1528-1533 (2012).
45. Broza YY, Kremer R, Tisch U et al. A nanomaterial-based breath test for short-Term follow-up after lung tumor resection. Nanomedicine 9, 15-21 (2012).
46. Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int. 27, 928-937 (1985).
47. Devarajan P. Review: Neutrophil gelatinase-Associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology 15, 419-428 (2010).
48. Malyszko J. Biomarkers of acute kidney injury in different clinical settings: A time to change the paradigm?. Kidney Blood Press. Res. 33(5), 368-382 (2010).
49. Cohen-Kaminsky S, Nakhleh M, Perros F et al. A proof of concept for the detection and classification of pulmonary arterial hypertension through breath analysis with a sensor array. Am. J. Respir. Crit. Care Med. 188, 756-759 (2013).
50. Lobue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int. J. Tuberc. Lung Dis. 14, 1226-1232 (2010).
51. Syhre M, Chambers ST. The scent of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 88, 317-323 (2008).
52. Syhre M, Manning L, Phuanukoonnon S, Harino P, Chambers ST. The scent of Mycobacterium tuberculosis-part II breath. Tuberculosis (Edinb.) 89, 263-266 (2009).
53. Peled N, Ionescu R, Nol P et al. Detection of volatile organic compounds in cattle naturally infected with Mycobacterium bovis. Sens. Actuat. B 171, 588-594 (2012).
54. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29 (2012).
55. Barash O, Peled N, Hirsch FR, Haick H. Sniffing the unique 'odor print' of non-small-cell lung cancer with gold nanoparticles. Small 5, 2618-2624 (2009).
56. Barash O, Peled N, Tisch U, Bunn PA, Hirsch FR, Haick H. Classification of the lung cancer histology by gold nanoparticle sensors. Nanomedicine 8, 580-589 (2012).
57. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 371(9625), 1695-1709 (2008).
58. Hakim M, Billan S, Tisch U et al. Diagnosis of head and neck cancer from exhaled breath. Br. J. Cancer 104, 1649-1655 (2011).
59. Gruber M, Tisch U, Jeries R et al. Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: A feasibility study. Br. J. Cancer 111 790-798 (2014).
60. Guray M, Sahin AA. Benign breast diseases: Classification, diagnosis, and management. Oncologist 11, 435-449 (2006).
61. Shuster G, Gallimidi Z, Reiss AH et al. Classification of breast cancer precursors through exhaled breath. Breast Cancer Res. Treat. 126, 791-796 (2011).